Bulwark Capital Corp »

Moonlake Immunot shares owned by Bulwark Capital Corp

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by Bulwark Capital Corp from 13F filings

Historical chart of Bulwark Capital Corp investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by Bulwark Capital Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by Bulwark Capital Corp

Quarter filed Position value Share count Share price at filing
2026-09-30 $5.9k 500 11.70

More positions owned by Bulwark Capital Corp

Pgim Ultra Short Bond Etf Etf (PULS)
Vanguard Morningstar Total Stock Market Etf Etf (VTI)
Ishares Core S&p 500 Etf Etf (IVV)
Schwab Us Tips Etf Etf (SCHP)
Jpmorgan Limited Duration Bond Etf Etf (JPLD)
Vanguard Short-term Inflation-protected Securities Etf Etf (VTIP)
Vanguard Information Technology Etf Etf (VGT)
Ishares Aaa Clo Active Etf Etf (CLOA)
Angel Oak Ultrashort Income Etf Etf (UYLD)
Microsoft Corp Stock (MSFT)
Janus Henderson Aaa Clo Etf Etf (JAAA)
Capital Group Dividend Value Etf Etf (CGDV)
Bondbloxx Bloomberg Six Month Target Duration Us Treasury Etf Etf (XHLF)
Invesco S&p 500 Top 50 Etf Etf (XLG)
Ishares Core S&p U.s. Growth Etf Etf (IUSG)

View all positions for Bulwark Capital Corp

Top funds holding Moonlake Immunot

BVF
Deep Track Capital
D. E. Shaw & Co
Cormorant Asset Management
Jupiter Topco
Logos Global Management
Weiss Asset Management LP[1
Citadel Advisors
Two Sigma Investments
MPM Oncology Impact Management
Vivo Capital
Jpmorgan Chase & Co
Jane Street
Point72 Asset Management
BlackRock

View all funds holding Moonlake Immunot